Home > Insider Trading > Filing (0000950170-23-032871)

Filing Details

Accession Number:: 0000950170-23-032871
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-07-13 17:15:30
Reporting Period:: 2023-07-11

Accepted Time:: 2023-07-13 17:15:30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1694665	Evelo Biosciences Inc.	EVLO	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1222012	Noubar Afeyan	55 Cambridge Parkway, Suite 800E Cambridge MA 02142	No	No	No	No
1400240	Flagship Pioneering Inc.	55 Cambridge Parkway, Suite 800E Cambridge MA 02142	No	No	No	No
1503559	Flagship Ventures Fund Iv, L.p.	55 Cambridge Parkway, Suite 800E Cambridge MA 02142	No	No	No	No
1508051	Flagship Ventures Fund Iv General Partner Llc	C/O Flagship Pioneering Inc. 55 Cambridge Parkway, Suite 800E Cambridge MA 02142	No	No	No	No
1780951	Nutritional Health Ltp Fund General Partner Llc	55 Cambridge Parkway, Suite 800E Cambridge MA 02142	No	No	No	No
1780956	Nutritional Health Ltp Fund, L.p.	55 Cambridge Parkway, Suite 800E Cambridge MA 02142	No	No	No	No
1805916	Flagship Pioneering Fund Vii, L.p.	55 Cambridge Parkway, Suite 800E Cambridge MA 02142	No	No	No	No
1805917	Flagship Pioneering Fund Vii General Partner Llc	55 Cambridge Parkway, Suite 800E Cambridge MA 02142	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-07-11	1,082,251	$2.31	1,461,795	No	4	P	Indirect	By Flagship Ventures Fund IV, L.P.
Common Stock	Acquisiton	2023-07-11	1,082,251	$2.31	1,493,241	No	4	P	Indirect	By Nutritional Health LTP Fund, L.P.
Common Stock	Acquisiton	2023-07-11	3,246,753	$2.31	3,931,685	No	4	P	Indirect	By Flagship Pioneering Fund VII, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Flagship Ventures Fund IV, L.P.
No	4	P	Indirect	By Nutritional Health LTP Fund, L.P.
No	4	P	Indirect	By Flagship Pioneering Fund VII, L.P.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	94,371	Indirect	By Flagship Ventures Fund IV-Rx, L.P.
Common Stock	274,766	Indirect	By Flagship Ventures Opportunities Fund I, L.P.
Common Stock	34,219	Indirect	By Flagship VentureLabs IV LLC
Common Stock	132,282	Indirect	By Flagship VentureLabs V LLC
Common Stock	210,064	Indirect	By Flagship Ventures Fund V, L.P.
Common Stock	80,494	Indirect	By Flagship V VentureLabs Rx Fund, L.P.
Common Stock	39,798	Indirect	By Nutritional Health Side Fund, L.P.
Common Stock	179,909	Indirect	By Nutritional Health Disruptive Innovation Fund, L.P.

Footnotes

On July 11, 2023, Flagship Ventures Fund IV, L.P. ("Flagship Fund IV"), Nutritional Health LTP Fund, L.P. ("Nutritional LTP") and Flagship Pioneering Fund VII, L.P. ("Flagship Fund VII") acquired 1,082,251 shares, 1,082,251 shares and 3,246,753 shares, respectively, of the Issuer's Common Stock in a private placement at a price of $2.31 per share.
Shares held by Flagship Fund IV. Flagship Ventures Fund IV General Partner LLC ("Flagship Fund IV GP") is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. ("Dr. Afeyan") is the sole manager of Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
Shares held by Nutritional LTP. Nutritional Health LTP Fund General Partner LLC ("Nutritional LTP GP") is the general partner of Nutritional LTP. Flagship Pioneering, Inc. ("Flagship Pioneering") is the manager of Nutritional LTP GP. Dr. Afeyan is the Chief Executive Officer, director and sole stockholder of Flagship Pioneering. Each of the reporting persons except for Nutritional LTP disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
Shares held by Flagship Fund VII. Flagship Pioneering Fund VII General Partner LLC ("Flagship Fund VII GP") is the general partner of Flagship Fund VII. Flagship Pioneering is the manager of Flagship Fund VII GP. Each of the reporting persons except for Flagship Fund VII disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
Shares held by Flagship Ventures Fund IV-Rx, L.P ("Flagship Fund IV-Rx"). Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. Each of the reporting persons except for Flagship Fund IV-Rx disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
Shares held by Flagship Ventures Opportunities Fund I, L.P. ("Flagship Opportunities I"). Flagship Ventures Opportunities Fund I General Partner LLC ("Flagship Opportunities GP") is the general partner of Flagship Opportunities I. Dr. Afeyan is the sole manager of Flagship Opportunities GP. Each of the reporting persons except for Flagship Opportunities I disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
Shares held by Flagship VentureLabs IV, LLC ("VentureLabs IV"). Flagship Fund IV is the manager of VentureLabs IV. Each of the reporting persons except for VentureLabs IV disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
Shares held by Flagship VentureLabs V LLC ("VentureLabs V"). Flagship VentureLabs V Manager LLC ("VentureLabs V Manager") serves as manager of VentureLabs V. Flagship Pioneering is the manager of VentureLabs V Manager. Each of the reporting persons except for VentureLabs V disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
Shares held by Flagship Ventures Fund V, L.P. ("Flagship Fund V"). Flagship Ventures Fund V General Partner LLC ("Flagship Fund V GP") is the general partner of Flagship Fund V. Dr. Afeyan serves as sole manager of Flagship Fund V. Each of the reporting persons except for Flagship Fund V disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
Shares held by Flagship V VentureLabs Rx Fund, L.P. ("VentureLabs Rx V"). Flagship Fund V GP is the general partner of VentureLabs Rx V. Each of the reporting persons except for VentureLabs Rx V disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
Shares held by Nutritional Health Side Fund, L.P. ("Nutritional Health Side Fund"). Flagship Fund V GP is the general partner of Nutritional Health Side Fund. Each of the reporting persons except for Nutritional Health Side Fund disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
Shares held by Nutritional Health Disruptive Innovation Fund, L.P. ("Nutritional Innovation Fund"). Flagship Fund V GP is the general partner of Nutritional Innovation Fund. Each of the reporting persons except for Nutritional Innovation Fund disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.